Psilocybin for Treatment of Obsessive Compulsive Disorder
Status:
Active, not recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This study will evaluate whether psilocybin, a hallucinogenic drug, improves symptoms of
obsessive compulsive disorder (OCD), whether it is safely tolerated as treatment of OCD, and
will investigate the mechanisms by which it works.